Zhenyu Lin
Huazhong University of Science and Technology Tongji Medical College Union Hospital · Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Zhenyu Lin as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 10:37 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT07847229 · A Prospective, Biomarker-Stratified Phase 2 Study: β-Hydroxybutyrate as a Predictive Biomarker for Short-Course Radiotherapy Followed by Chemotherapy Plus PD-1 Inhibitor Versus Chemotherapy Alone in Locally Advanced Rectal CancerTao Zhang · not yet recruiting · Rectal Cancer, Radiotherapy, Immunotherapy · principal investigator
- Ph2NCT07239466 · A Pilot Study Evaluating β-hydroxybutyrate Supplementation Concomitant to Short-Course Radiotherapy Followed by Immunotherapy Combined With CAPEOX Neoadjuvant Therapy in Patients With Locally Advanced Rectal CancerTao Zhang · recruiting · Rectal Cancer, Radiotherapy, Immunotherapy · principal investigator
- Ph3NCT07113275 · A Clinical Trial Comparing Long-Course Versus Short-Course Radiotherapy Followed by Immunotherapy Combined With Total Neoadjuvant Therapy (TNT) to Long-Course Radiotherapy Followed by TNT in Locally Advanced Rectal CancerTao Zhang · recruiting · Rectal Cancer, Total Neoadjuvant Therapy, Radiotherapy · principal investigator
- Ph2NCT06542588 · Short-Course Radiotherapy Followed by Neoadjuvant Chemotherapy, HLX07and Serplulimab in LARCUnion Hospital, Tongji Medical College, Huazhong University of Science and Technology · recruiting · Rectal Cancer · principal investigator
- N/ANCT06099314 · Fruquintinib in the Cross-line Treatment of Refractory mCRCUnion Hospital, Tongji Medical College, Huazhong University of Science and Technology · unknown · Fruquintinib, Metastatic Colorectal Cancer · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 10:37 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name in colorectal cancer, ranked by citations from NIH iCite, fetched 2026-11-12 10:37 UTC. The ranking covers the 200 most relevant of 9 PubMed records, and a shared surname and initials can bring in a namesake. All 9 on PubMed
- Phase II, single-arm trial of preoperative short-course radiotherapy followed by chemotherapy and camrelizumab in locally advanced rectal cancer.J Immunother Cancer · 2021153 citationsRCR 7.4
- 121 citationsRCR 12.6
- 48 citationsRCR 2.2
- Clinical Usefulness and Prognostic Value of Red Cell Distribution Width in Colorectal Cancer.Biomed Res Int · 201832 citationsRCR 1.4
- 6 citationsRCR 1.5
- 4 citationsRCR 0.8
- Capecitabine maintenance therapy in metastatic colorectal cancer patients with no evidence of disease: CAMCO trial.Future Oncol · 20233 citationsRCR 0.3